Safety and efficacy results of simulated post-exposure prophylaxis with human immune globulin (HRIG; KEDRAB) co-administered with active vaccine in healthy subjects: a comparative phase 2/3 trial
We conducted a clinical trial to assess the safety and putative efficacy of an additional human rabies immune globulin (HRIG; KEDRAB) versus an older product (Comparator, HyperRAB S/D® [Grifols]) and determine whether HRIG interferes with development of endogenous antibodies versus Comparator, when...
Saved in:
Main Authors: | Mark A. Matson (Author), Eran Schenker (Author), Michal Stein (Author), Vladislava Zamfirova (Author), Huy-Binh Nguyen (Author), Garrett E. Bergman (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2020-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Commentary on the implications of safety and efficacy studies in pediatric patients with administration of human rabies immune globulin (HRIG)?
by: Jerry Siegel, et al.
Published: (2022) -
Effectiveness and Safety of an Intravenous Immune Globulin (IVIG) Preparation in Post-exposure Prophylaxis (PEP) Against Measles in Infants
by: Benno Kohlmaier, et al.
Published: (2021) -
Rabies postexposure prophylaxis in the United States: Opportunities to improve access, coordination, and delivery.
by: Gavin T Howington, et al.
Published: (2021) -
Adherence to guideline recommendations for human rabies immune globulin patient selection, dosing, timing, and anatomical site of administration in rabies postexposure prophylaxis
by: Grace S. Hwang, et al.
Published: (2020) -
Trial of Immune Globulin in Infant Botulism
by: J Gordon Millichap
Published: (2006)